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Abstract: Brucellosis is one of the most important worldwide zoonoses of many countries including
Egypt. Camel brucellosis has not gained much attention in Egypt yet. This study is focused on the
three governorates with the highest camel populations and the largest camel markets in the country to
determine the disease seroprevalence and identify the Brucella species in local camel holdings. In total,
381 serum samples were collected from male and female camels from Giza, Aswan, and Al-Bahr
Al-Ahmar (the Red Sea) governorates. Samples were serologically examined using the Rose–Bengal
plate test (RBPT), indirect ELISA (i-ELISA), competitive ELISA (c-ELISA) and complement fixation
test (CFT). Brucella antibodies were detected in 59 (15.5%), 87 (22.8%), 77 (20.2%) and 118 (31.0%)
of sera by RBPT, i-ELISA, c-ELISA and CFT, respectively. Using real-time PCR, Brucella DNA was
amplified in 32 (8.4%) seropositive samples including Brucella abortus (25/32), Brucella suis (5/32) and
Brucella melitensis (2/32), defining a complex epidemiological status. To the best of our knowledge,
this is the first study reporting Brucella suis DNA in camel serum. The risk-associated factors including
age, sex, breed and geographical distribution were statistically analyzed, showing non-significant
association with seroprevalence. The results of this study will raise awareness for camel brucellosis
and help develop effective control strategies.
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1. Introduction
Brucellosis is a global zoonotic disease affecting cattle, sheep, goats, camels, pigs and wildlife as
well as humans. It is well controlled in many countries but is still endemic in many others with high
records in humans in the Middle East and central Asian regions [1]. Brucellosis in camels was first
reported in 1931 [2]. Since then, it has been testified by all camel rearing countries like Sudan, Ethiopia,
Somalia, Kenya, Nigeria, Jordan and Egypt but not Australia [3]. There is no separate specific species
of Brucella that displays a preference for camels as they can be infected by those that have already
been shown to be prevalent in bovines, ovines and caprines [4–6]. The clinical picture of brucellosis
in camels can vary from asymptomatic to abortion, retention of fetal membranes, weak offspring,
impaired fertility and delayed sexual maturity in females and orchitis accompanied by lameness in
males [2,4,7].
The 120000 camels kept in Egypt represent 1.1% and 0.9% of the total number of camels in Arab
countries and Africa, respectively [8]. Higher numbers of camels are raised in countries of the Horn
of Africa (Djibouti, Eritrea, Somalia and Ethiopia) as well as parts of Kenya, Sudan, and Uganda [2].
Camels are usually imported from Sudan to Egypt. About half of the camel population lives in the
Shalateen area of Al-Bahr Al-Ahmar (the Red Sea) governorate.
Brucellosis has been endemic in Egypt for thousands of years [9,10]. The disease has been
detected in livestock predominantly in ruminants with prevalences from 2.47% to 26.66% [11–13].
Brucella abortus and B. melitensis were isolated from all livestock species and humans but B. suis was
identified in cattle and pigs only [10,14,15]. There are few seroprevalence reports on camel brucellosis
in Egypt, as the disease has not received much attention.
For serological testing, a screening test of high sensitivity is usually followed by a confirmatory
test of high specificity [16]. Rose-Bengal plate test (RBPT), complement fixation test (CFT), standard
agglutination test (SAT), competitive enzyme-linked immunosorbent assay (c-ELISA), fluorescence
polarization assay (FPA) and indirect ELISA (i-ELISA) have been used for detection of anti-Brucella
antibodies in camel sera [2]. Culture of brucellae is sometimes difficult and time consuming.
Additionally, this method poses a risk to laboratory personnel and requires specific biosafety
measures [17]. Thus, detection of Brucella DNA by PCR in clinical samples is considered a preferred tool
for definitive diagnosis of brucellosis [18]. Combination of PCR with at least one of the conventionally
used serological tests (e.g., RBPT, SAT, ELISA) was recommended for developing countries [19].
Infection in humans may occur by direct contact with infected animals or consumption of
contaminated raw camel milk [2]. Outbreaks of human brucellosis by consumption of infected raw
camel milk have been reported in Qatar, Israel and countries of the African Horn [20–22]. Brucellosis
proved to be a serious occupational health hazard to livestock handlers especially abattoir workers in
Egypt [23].
Considering public health concerns and zoonotic importance of brucellosis, the present study
aimed at serological monitoring of camelid brucellosis with molecular identification of Brucella species
involved in Egypt, filling a gap in knowledge of the disease epidemiology.
2. Materials and Methods
2.1. Study Area and Sera Collection
The study was conducted from March 2017 to November 2019. Sera of the Arabian one-humped
or dromedary camel (Camelus dromedarius) were collected from Giza, Aswan and Al-Bahr Al-Ahmar
(the Red Sea) governorates in Egypt. These governorates house the highest camel populations and the
largest camel markets, viz. Birqash market in Imbaba (Giza), Daraw market in Aswan and Shalateen
International Market in Al-Bahr Al-Ahmar (the Red Sea). The main portals of entry for camels imported
from Sudan and Somalia, as well as the main local routes of camel transport to central markets,
are shown in Figure 1. Camels usually live for some years on farms to produce milk, to be used for
cheesemaking, tourism, etc.
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Figure 1. Map of Egypt showing the geographic distribution and the main portals of entry of camels 
imported from Sudan and Somalia, as well as the main local routes of camel transport to central 
markets. 
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2.2. Ethics Statement
This study was carried out in strict accordance with the Guidelines of the Egyptian Network of
Research Ethics Committees (ENREC), which complies with the international laws and regulations
regarding the ethical considerations in research. All efforts were made to minimize animal suffering
and to reduce the number of animals used.
2.3. Detection of Anti-Brucella Antibodies
All sera were screened for anti-Brucella antibodies by RBPT (IDEXX, Westbrook, ME, USA),
indirect ELISA (ID Screen® Brucellosis Serum Indirect Multi-species (protein G-HRP conjugate),
IDVet Innovative Diagnostics, Grabels, France), c-ELISA (SVANOVIR® Brucella-Ab c-ELISA kit,
Boehringer Ingelheim Animal Health International GmbH, Ingelheim, Germany) and complement
fixation test (CFT) according to the manufacturers‘ instructions.
These tests are mainly standardized for use in cattle, but the OIE recommends their use in
camels as well after validation [24]. The RBPT antigen was standardized against the OIE International
Standard Serum (OIEISS) to give a positive reaction at a dilution of 1:45 and a negative reaction at
a dilution of 1:55. The CFT followed the range of recommendations by the OIE [24]. This included
an antigen standardized to give 2:200 of the OIEISS (one 50% hemolytic unit), 2% sheep RBCs,
two full (100% hemolysis) units of complement and four full units of hemolysin. Serum showing a
value ≥ 20 ICFTU/mL of the OIEISS was considered positive for CFT. ELISA methods conducted and
results were calculated in accordance with the manufacturer’s instructions.
2.4. Molecular Detection of Brucella spp. DNA
DNA was extracted automatically from serum samples by QIAcube machine (QIAGEN, Hilden,
Germany) using the QIAamp DNA Mini Kit (QIAGEN, Hilden, Germany) according to the instructions
of the manufacturer. Reference strains of Escherichia coli (ATCC 25922) and serum form non infected
animals were used as negative extraction control in each cycle. Genus Brucella and species-specific
(B. abortus, B. melitensis and B. suis) real-time PCRs were used for detection of Brucella DNA. PCR was
performed using primer and probe (Jena Bioscience GmbH, Jena, Germany) sets as given in Table 1.
The PCR protocol was modified (volume and temperature) than previously published [25,26]
to obtain optimal results as DNA used in this study as template was extracted from serum not
from bacterial colonies. Briefly, PCR reaction was performed in 15 µL multiplex PCR mixture with
2× TaqMan™ environmental master mix (Applied Biosystems®, Darmstadt, Germany), 0.2 µM
of each primer, 0.1 µM of each probe and 5 µL of template DNA. Amplification and real-time
fluorescence detection were carried out on a CFX96™ Real-Time PCR Detection System (Bio-Rad
Laboratories, Inc., Hercules, CA, USA). The reaction conditions were: decontamination at 50 ◦C for
2 min, initial denaturation at 95 ◦C for 10 min followed by 50 cycles of denaturing at 95 ◦C for 25 s
and anealing/elongation at 57 ◦C (B. abortus and B. melitensis) [25] and 60 ◦C (B. suis) [26] for one
minute. Sample data scores were confirmed by visual inspection of graphical plots and Cycle Threshold
(CT) values for each sample were obtained. CT values ≤ 38 were considered positive after in house
validation to avoid false positive results. The CT values of negative extraction controls were either
>38 or not detected. Reference strains of B. abortus S-99 (ATCC 23448), B. melitensis 16M (ATCC 23456)
and B. suis biovar 1 (ATCC 23444) were used as positive controls. Reference strains of Escherichia coli
(ATCC 25922), Staphylococcus aureus (ATCC 25923) and Ochrobactrum intermedium (DSM 17986) were
used as negative controls.
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Table 1. Primer and probe sequences used in real-time PCR assays for the detection of Brucella spp.,
B. abortus, B. melitensis and B. suis in camel sera, Egypt.
Target Primer and Probe Sequences Reference
Brucella spp.
5′-GCT CGG TTG CCA ATA TCA ATG C-3´ Forward
[25]
5′-GGG TAA AGC GTC GCC AGA AG-3´ Reverse
6-FAM-AAA TCT TCC ACC TTG CCC TTG CCA TCA-MGB Probe
B. abortus
5′-GCG GCT TTT CTA CGG TAT TC-3´ Forward
5′-CAT GCG CTA TGA TCT GGT TAC G-3´ Reverse
Hex-CGC TCA TGC TCG CCA GAC TTC AAT G-BHQ1 Probe
B. melitensis
5′-AAC AAG CGG CAC CCC TAA AA-3´ Forward
5′-CAT GCG CTA TGA TCT GGT TAC G-3´ Reverse
Cy5-CAG GAG TGT TTC GGC TCA GAA TAA TCC
ACA-BHQ2 Probe
B. suis
5′-GCC AAA TAT CCA TGC GGG AAG-3´ Forward
[26]5′-TGG GCA TTC TCT ACG GTG TG-3´ Reverse
VIC-TTG CGC TTT TGT GAT CTT TGC TTA TGG-MGB Probe
2.5. Statistical Analysis
The agreement of positive camel results of serological tests and real-time PCR was expressed using
Venn diagrams. Correlation of potential risk factors (geographical location, breed type, sex and age)
with seroprevalence and molecular detection of 381 camels was analyzed using Pearson’s Chi-squared
test (X2) and odds ratio (OR). The estimation of X2 was done using RStudio Version 1.1.463.
3. Results
3.1. Seroprevalence of Anti-Brucella Antibodies in Camel Sera
Out of 381 camel serum samples, 59 (15.5%), 87 (22.8%), 77 (20.2%) and 118 (31.0%) were found
positive for Brucella antibodies by RBPT, i-ELISA, c-ELISA and CFT, respectively (Table 2). Higher
numbers of seropositive animals, i.e., 17.7%, 25.8%, 22.0% and 31.7% were detected from Aswan
governorate using RBPT, i-ELISA, c-ELISA and CFT, respectively. The corresponding values from
Giza governorate were 14.2%, 22.6%, 14.2% and 31.1% and from Al-Bahr Al-Ahmar (the Red Sea)
governorate were 12.4%, 16.9%, 23.6% and 29.2% in that order. Only 16 serum samples were found
seropositive by all serological tests.
Higher seroprevalences were recorded in male animals (17.6%, 24.1%, 23.4% and 34.9%) than
female animals (8.1%, 18.6%, 12.8% and 17.4%) using RBPT, i-ELISA, c-ELISA and CFT, respectively,
in the investigated governorates (Table 2).
Correlation of potential risk factors (geographical location, breed, sex and age) with seroprevalence
and molecular detection of Brucella spp. in 381 camels is shown in Table 3. Using i-ELISA, 25.8% of
seropositive samples were found in Aswan, 22.6% in Giza and 16.9% in Al-Bahr Al-Ahmar (the Red Sea)
(Table 3).
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Seroprevalence n (%) Molecular Identification




male 55 11 (20.0) 17 (30.9) 7 (12.7) 28 (50.9) 3 (5.5) 3 B. abortus 37, 36, 35
female 51 4 (7.8) 7 (13.7) 8 (15.7) 5 (9.8) 6 (11.8) 6 B. abortus 30, 32, 33, 36, 37
Sub-total 106 15 (14.2) 24 (22.6) 15 (14.2) 33 (31.1) 9 (8.5)
Aswan male 161
30 (18.6) 41 (25.5) 39 (24.2) 51 (31.7) 7 (4.4)
6 B. abortus 37, 37, 36, 36, 36, 36
1 B. melitensis 34
female 25 3 (12.0) 7 (28.0) 2 (8.0) 8 (32.0) 1 (4.0) 1 B. abortus 36




male 79 11(13.9) 13 (16.5) 20 (25.3) 24 (30.4) 14 (17.7)
8 B. abortus 37, 35, 31, 37, 35, 32, 36, 35
1 B. melitensis 36
5 B. suis 37, 36, 33, 28, 37
female 10 0 (0.0) 2 (20.0) 1 (10.0) 2 (20.0) 1 (10.0) 1 B. abortus 37
Sub-total 89 11 (12.4) 15 (16.9) 21 (23.6) 26 (29.2) 15 (16.9)
Grand-total 381 59 (15.5) 87 (22.8) 77 (20.2) 118 (31.0) 32 (8.4)
* RBPT: Rose-Bengal plate test; i-ELISA: indirect ELISA; c-ELISA: competitive ELISA; CFT: complement fixation test. ** Cq/Ct-values: cycle quantification/ cycle threshold values.
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Table 3. Relation of the risk factors with the seroprevalence and molecular detection of brucellosis in 381camels, Egypt.
Variable
Seroprevalence n (%) Molecular Identification
RBPT * i-ELISA * c-ELISA * CFT * Real-Time PCRn (%) Brucella DNA Identification
Geographical location
Aswan (n = 186) 33 (17.7) 48 (25.8) 41 (22.0) 59 (31.7) 8 (4.3) 7 B. abortus1 B. melitensis
Giza (n =106) 15 (14.2) 24 (22.6) 15 (14.2) 33 (31.1) 9 (8.5) 9 B. abortus




p-value ** 0.4688 0.3205 0.4171
NA NA
X2 1.5153 2.2757 1.7489
Df 2
95% CI - - -
OR - - -
Breed




Al-Ebadi (n = 93) 16 (17.2) 26 (28.0) 22 (23.7) 30 (32.3) 4 (4.3) 3 B. abortus1 B. melitensis
Al-Zemkly (n = 106) 15 (14.2) 24 (22.6) 15 (14.2) 33 (31.1) 9 (8.5) 9 B. abortus
Al-Zubaidi (n = 93) 17 (18.3) 22 (23.7) 19 (20.4) 29 (31.2) 4 (4.3) 4 B. abortus
p-value ** 0.6775 0.4658 0.5823
NA NA
X2 1.5205 2.5532 1.9524
Df 3
95% CI - - -
OR - - -
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Table 3. Cont.
Variable
Seroprevalence n (%) Molecular Identification
RBPT * i-ELISA * c-ELISA * CFT * Real-Time PCRn (%) Brucella DNA Identification
Sex
Females (n = 86) 7 (8.1) 16 (18.6) 11 (12.8) 15 (17.4) 8 (9.3) 8 B. abortus




p-value ** 0.7177 0.3515 0.9164
NA NA
X2 0.13075 0.86806 0.011028
Df 1
95% CI 0.2819–2.2582 0.6333–3.1044 0.4215–2.4729
OR 0.8438063 1.4091 1.0436
Age




≥8–11 years (n = 68) 13 (19.1) 19 (27.9) 20 (29.4) 22 (32.4) 3 (4.4) 2 B. abortus1 B. melitensis
11–13 years (n = 51) 4 (7.8) 7 (13.7) 8 (15.7) 5 (9.8) 6 (11.8) 6 B. abortus
>13–15 years (n = 35) 3 (8.6) 9 (25.7) 3 (8.6) 10 (28.6) 2 (5.7) 2 B. abortus
p-value ** 0.7844 0.5792 0.1672
NA NA
X2 1.0699 1.9674 5.0641
Df 3
95% CI - - -
OR - - -
* The univariate analysis was based on the RBPT, i-ELISA and c-ELISA results; OR: odds ratio; CI: confidence interval; df: degree of freedom; X2: Pearson’s Chi-squared test; Ref: reference.
** (Statistical value of significance: p-value ≤ 0.05).
Microorganisms 2020, 8, 1035 9 of 14
The seroprevalence in different breeds using i-ELISA was 16.9% (15 out of 89) in Al-Beshary, 28.0%
(26 out of 93) in Al-Ebadi, 22.6% (24 out of 106) in Al-Zemkly and 23.7% (22 out of 93) in Al-Zubaidi
breeds (Table 3).
The results of this study showed relatively higher seropositive males (17.6%, 24.1% and 23.4%)
than females (8.1%, 18.6% and 12.8%) using RBPT, iELISA and cELISA, respectively with confidence
intervals (95% CI) 0.2819–2.2582, 0.6333–3.1044 and 0.4215–2.4729, respectively.
Seroprevalences of age groups were 22.9% (52/227), 27.9% (19/68), 13.7% (7/51) and 25.7% (9/35)
in animals of <8 years, ≥8–11 years, 11–13 years and >13–15 years using i-ELISA, respectively.
In the univariate analysis based on i-ELISA, all variables (geographical location, breed, age and sex)
showed no association with seroprevalence (Table 3).
3.2. Detection of Brucella spp. DNA in Camel Sera
Brucella DNA was detected in serum samples positive by either RBPT, i-ELISA, c-ELISA or CFT.
Brucella DNA was detected in 32 (8.4%) samples and was typed as B. abortus (25/32), B. suis (5/32) and
B. melitensis (2/32) (Table 2). Brucella DNA was detected in 4.3%, 8.49% and 16.8% of camels from
Aswan, Giza and Al-Bahr Al-Ahmar (the Red Sea), respectively. Brucella DNA was amplified in 8.14%
(24 out of 295; 17 B. abortus, 5 B. suis and 2 B. melitensis) and 9.3% (8 out of 86; B. abortus) samples of
male and female camels, respectively. The DNA concentration of positive samples was not sufficient
for optimal sequencing. Sera from Al-Bahr Al-Ahmar (the Red Sea) governorate were more often
positive in PCR (16.8%) than those of Giza (8.5%) and Aswan governorates (4.3%).
Brucella DNA was identified in all camel breeds (Table 3). Identification of B. suis DNA from
camel sera is a new finding of this study. B. suis was only identified in 5 seropositive male animals of
breed Al-Beshary in Al-Bahr Al-Ahmar (the Red Sea) governorate. The Brucella DNA extracted from
seronegative samples by either RBPT, i-ELISA, c-ELISA or CFT was either not amplified or showed CT
values > 38 by real-time PCR.
3.3. Statistical Analysis
Investigating the agreement of the results of positive cases detected by serological tests and
real-time PCR, the Venn diagram (Figure 2) reveals that 60, 18, 13 and 5 camels were identified as
positives by CFT, c-ELISA, i-ELISA and RBPT only. There were only four animals classified as positive
by all serological assays and real-time PCR. The CFT agreed with real-time PCR, i-ELISA, c-ELISA and
RBPT in 12, 34, 33 and 32 positive animals, respectively. Indirect ELISA and c-ELISA had 40 positive
results (Figure 2).
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4. Discussion
Despite the available data on Brucella infection in humans and ruminants, little is known about
the status of camel brucellosis in Egypt. The identification of Brucella spp. in various farm animals and
wildlife species (viz. cattle, buffalo, sheep, goat, camel, bison, African buffalo, Alpine ibex) highlights
their role in disease spread [27–31]. Consumption of raw milk and dairy products of infected camels
was associated with brucellosis in humans [20–22]. This study is investigating camel brucellosis in three
Egyptian governorates with the highest number of camels, viz. Giza, Aswan and Al-Bahr Al-Ahmar
(the Red Sea). The latter two governorates are the main entry portals for camels imported from Sudan.
Giza receives imported Sudanese camels from Aswan as well as Somali camels shipped to the port of
Suez. Apart from camels smuggled through the desert, Egypt has been importing camels officially
from east Africa where brucellosis is enzootic in ruminants including camels [19,32,33]. The fact that
these camels are imported does not preclude the possibility of acquiring brucellosis from a local source.
In this study, 381 camel sera were investigated serologically and 59 (15.5%), 87 (22.8%), 77 (20.2%)
and 118 (31.0%) were found positive for anti-Brucella antibodies by RBPT, i-ELISA, c-ELISA and CFT,
respectively (Table 2). A previous report from camel-keeping countries has revealed seroprevalence of
camel brucellosis ranging from 1.0 to 23.3% [4]. The seroprevalence figures of brucellosis in apparently
healthy Sudanese camels were 79.3%, 71.4%, 70.7%, 70.6% and 68.8% using FPA, CFT, RBT, SAT and
c-ELISA [19]. In camels, the prevalence was 12.9% in the Shalateen region of the Red Sea governorate [5].
One study from the regions of Siwa Oasis, Asyut and Cairo reported a prevalence of 4.17% using
RBPT [34]. A similar study from Beheira district revealed prevalence figures of 8.74% and 9.26%
using RBPT and ELISA, respectively [35]. The general consistency of seroprevalence data from all the
governorates as revealed by i-ELISA (25.8%, 22.6% and 16.9%) in Aswan, Giza and Al-Bahr Al-Ahmar
respectively) is a reflection of the continuous flow and regular distribution of imported camels from
the same source countries.
In the current study, Brucella DNA was detected in 32 (8.4%) of all investigated camel sera (Table 2).
Quantitative multiplex real-time PCR confirmed the presence of Brucella DNAs of 25 B. abortus, 5 B. suis
and 2 B. melitensis. Detection of B. abortus DNA in the three target governorates in addition to
B. melitensis in camels reared in Aswan and Al-Bahr Al-Ahmar (the Red Sea) governorates was
expected as previous reports showed the endemicity of B. melitensis and B. abortus in these regions
already [10]. Previously, B. melitensis was isolated from camel stomach contents of an aborted fetus [5]
as well as from whole citrated blood samples from Al-Bahr Al-Ahmar (the Red Sea) governorate [36].
Similar studies reported the identification of B. melitensis DNA from camel milk from Giza and
Aswan [34,37]. The source of B. melitensis in camels might be attributed to small ruminants as camels
are usually reared in herds with sheep and goats in mobile flocks [31,38].
As B. abortus is enzootic in Egypt, the detection of a relevant number of camel sera containing
B. abortus DNA might indicate that B. abortus may be the predominant spp. in camels in this region but
more results are needed to confirm this. Brucella abortus has been isolated from camels in Sudan and it
can be speculated that camels were infected by cattle, the primary hosts of B. abortus [39]. These data
do not allow to speculate if camels were already infected when imported or that they got infected
in Egypt. Interestingly, more positive serum samples were collected from Al-Bahr Al-Ahmar (the
Red Sea) governorate sharing common borders with Sudan. This governorate hosts about half of
the Egyptian camels, a fact that may favour the spread of brucellosis in these regions [8]. The very
low amount of Brucella DNA extracted from camel sera hindered biotyping. Further investigation
of the Egyptian B. abortus strain is necessary to prove or deny the epidemiological relation with the
Sudanese B. abortus (biovar 6) strains detected in cattle in Darfour [40] and sheep in Kassala [41] as
well as B. abortus biovar 3 from camels in Eastern Sudan [42]. Camel herds move between the states of
North Sudan [43] and they are reared with cattle, sheep and goats [31]. Camels from the whole Darfour
sector usually gather at Southern Darfour during the autumn months seeking water of the tropical
heavy rain season. There, they also mingle intensely with cattle again. Unlike camels, Sudanese cattle
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do cross the Sudanese borders during the dry season to South Sudan, Central African Republic and
Congo reaching as far as Niger and Mali to the west.
The detection of B. suis DNA is a new finding of this study probably attributable to the first use of
recently developed highly sensitive and specific primer for B. suis biovars 1 to 4 to test camel sera [26].
However, the identification of B. suis in the present study is not unexpected as B. suis has previously
been isolated from cattle [10] and B. suis or its DNA was identified in pigs in Egypt [15,44].
The source of B. suis in camels could be traceable to either domestic or wild pigs, e.g., the wild
boars (Sus scrofa) of the adjacent Eastern Desert. Being a border governorate with Sudan, Al-Bahr
Al-Ahmar (the Red Sea), is also likely to have B. suis imported from Sudan, where some pig farms
in Khartoum state to the west of Kassala state exist. The uncontrolled transboundary movement of
Sudanese cattle to adjacent African countries, i.e., South Sudan and Central African Republic may
contribute to the spread of B. suis as both states have domestic and wild pigs [45]. The countries of
the Horn of Africa, with huge camel populations have similar restricted pig populations comparable
to Egypt in contrast to Uganda [45]. The exact source of B. suis should be traced to stop further
transmission as camels could have acquired the disease from a local source.
Identification of risk factors is crucial for control of brucellosis. Animal related risk factors (age, sex,
breed and species), farm management, geographical distribution, herd management and farmers‘
awareness of brucellosis have been associated with the prevalence of brucellosis [46]. In this study,
the seroprevalences of age groups were 22.9% (52/227), 27.9% (19/68), 13.7% (7/51) and 25.7% (9/35) in
animals of <8 years,≥8–11 years, 11–13 years and >13–15 years using i-ELISA, respectively. In a previous
study, the seroprevalence was significantly higher (29.4%) in camels brought for slaughtering at Akaki
abattoir, Ethiopia of the 5–9 years age group when compared to other age groups (0–4.8%) using
RBPT [47]. However, known risk factors (age, sex, breed and locality) were found unrelated, which is
consistent with a previously published report [48]. Rearing of camels with other farm animals might
be identified as an important risk factor of camel brucellosis as previously described [2,47,49,50].
None of the tests can differentiate among B. abortus, B. suis and B. melitensis. Many immunoassays
are available with different sensitivity and specificity but they must be used in accordance with strict
standardization rules and meet the requirements laid down by the OIE [24]. An obvious discrepancy
among the tests used in this study was seen: (CFT (31.0%), i-ELISA (22.8%), c-ELISA (20.2%), RBPT
(15.5%) and real-time PCR (8.4%)). Although these samples were not taken according to the sampling
plan of the Egyptian surveillance policy of ruminants, the ranges were in agreement with the previously
published reviews and reports of camel brucellosis (ranging from 1.0% to 24.0%) in Egypt [4,5,34,51].
Interestingly, the results of this study showed relatively higher seropositive males (17.6%, 24.1%
and 23.4%) than females (8.1%, 18.6% and 12.8%) using RBPT, i-ELISA and c-ELISA, respectively.
This may be due to the fact that the vast majority of imported camels are males for slaughter with
some females that farmers usually keep for breeding.
Of the 32 real-time PCR positive cases, the i-ELISA identified 21 followed by the c-ELISA (18) and
the CFT and the RBPT each detected 12. In terms of positive camel recognition, the CFT revealed the
highest number (118), followed by the i-ELISA (87), the c-ELISA (77), the RBPT (59), and finally the
real-time PCR (32), with exclusive detections of 60, 18, 13, 5 and 0 by every single test, respectively.
It is noteworthy that the 60 CFT positive samples that were negative by all other tests revealed low
titers of 1:10 or 1:20 and rarely 1:40.
The nature of camelid humoral immune response and the unique nature of their heavy chain
antibodies might be an explanation for these puzzling results. A reduced sensitivity of c-ELISA has
been reported previously [52]. These findings call for validation and standardization of tested kits for
camel brucellosis and in the worst case scenario for the development of new “camelid” diagnostics.
5. Conclusions
Under conditions of this investigation, DNA of three Brucella species was identified in 32 camel
sera. B. abortus was the most common (25 camels), followed by B. suis in 5 camels and B. melitensis in
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only 2 camels. To the best of our knowledge, this is the first study reporting the identification of B. suis
DNA in serum from camels. As camels in this study were apparently healthy, we believe that camels
can act both as a reservoir of brucellosis and as a source of infection to other camels. The relative
high seropositive camels in this study might reflect that the camels were imported from brucellosis
infected herds.
The endemic nature of the disease together with the DNA identification of the three classic Brucella
species in camel sera demonstrate complicated epidemiological situation that needs careful handling.
Further investigation is needed to assess the prevalence of Brucella species particularly B. suis in camels
as well as biovar and genotype identification. More attention should be paid to the standardization of
serological tests for brucellosis diagnosis in camels.
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